Claims
- 1. A liquid suppository composition comprising:a) 1-5 wt. % of diclofenac sodium; b) 25-40 wt. % of a solid-phase poloxamer mixture, the mixture containing at least two poloxamers; and c) 0.1-1.0 wt. % of at least one polymer selected from the group consisting of polyethylene oxide and polyvinylpyrrolidone.
- 2. The liquid suppository composition according to claim 1, wherein the solid-phase poloxamer mixture consists of poloxamer 407 and poloxamer 188.
- 3. The liquid suppository composition according to claim 2, wherein the weight ratio of both poloxamer 407 and poloxamer 188 is 1:1-1.5.
Priority Claims (1)
Number |
Date |
Country |
Kind |
99/6057 |
Feb 1999 |
KR |
|
CROSS REFERENCE TO RELATED APPLICATIONS
This application is a continuation of co-pending International Patent Application Number PCT/KR00/00143, filed Feb. 23, 2000, and claims priority from Korean Patent Application Number 1999/6057, filed Feb. 24, 1999. The entire disclosure of the prior applications are incorporated herein by reference.
US Referenced Citations (2)
Number |
Name |
Date |
Kind |
4946870 |
Partain, III et al. |
Aug 1990 |
A |
5346703 |
Viegas et al. |
Sep 1994 |
A |
Foreign Referenced Citations (6)
Number |
Date |
Country |
0 103 995 |
Mar 1984 |
EP |
0551626 |
Jul 1993 |
EP |
WO 9403157 |
Feb 1994 |
WO |
WO 9403186 |
Feb 1994 |
WO |
WO 9730693 |
Aug 1997 |
WO |
WO 9734580 |
Sep 1997 |
WO |
Continuations (1)
|
Number |
Date |
Country |
Parent |
PCT/KR00/00143 |
Feb 2000 |
US |
Child |
09/938797 |
|
US |